ArticleOncotarget2016

Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling.

Bin Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.